The Cancer Institute of New Jersey Foundation

blank
blank

Board of Trustees


WILLIAM WOOD ALLEN
Chief Executive Officer
WoodAllen Capital Management, LLC

PETER S. AMENTA, M.D., Ph.D.*
Dean
UMDNJ-Robert Wood Johnson Medical School

SUBHA V. BARRY - Chair

THOMAS A. BRACKEN
President
TriState Capital Bank

ROBERT E. CAMPBELL
Chair, CINJ Advisory Council
Johnson & Johnson, Vice Chairman (Retired)

ROBERT S. DiPAOLA, M.D.*
Director
The Cancer Institute of New Jersey
Professor of Medicine
UMDNJ, Robert Wood Johnson Medical School

JEFFREY N. EDWARDS
Partner
New Vernon Capital, LLC

CHRISTIANA FOGLIO
President
Care One Companies

AUDREY GOULD
Senior Vice President
The Gould Group of Wachovia Securities

WILLIAM N. HAIT, M.D., Ph.D.
Senior Vice President
Worldwide Head of Hematology/Oncology Research and Development
Johnson & Johnson Pharmaceutical Research and Development, LLC

RONALD J. LEVINE, Esq.
Partner
Herrick, Feinstein, LLP, Newark, NJ

DUNCAN L. MacMILLAN
Co-Founder
Bloomberg LP

HON. EDWARD J. McKENNA, JR., ESQ.
Senior Partner
McKenna, Dupont, Higgins & Stone

PAUL MIGNON
President and Chief Operating Officer
Ventiv Pharma Teams
inVentiv Commercial Services

MICHELLE MORTON
President and Chief Executive Officer
Pacific American Securities, LLC

DENISE V. RODGERS, MD
Executive Vice President for Academic and Clinical Affairs
University of Medicine and Dentistry of New Jersey

RICHARD C. ROSENZWEIG, Esq.
Associate General Counsel
C.R. Bard, Inc.

LESLIE LOGAN TAYLOR
Partner
Matrix Development Group

JOHN R. WHITMAN
Managing Partner
Sycamore Management Corporation

SUSAN WOLFORD
Managing Director and Sector Head
BMO Capital Markets Business Services & Media Group

ARSHAD R. ZAKARIA
President and Chief Executive Officer
New Vernon Capital, LLC


*Ex-Officio



blank

blank
What's New at CINJ

Vaccine Injection Targeted in Building a Better ‘Bull’s-Eye’ to Fight Prostate Cancer: Clinical Trial at CINJ Opens

CINJ Study Shows Drug for Lou Gehrig’s Disease Further Validated for Melanoma Treatment Benefit

CINJ Researchers Identify a Mechanism that Promotes Negative Function in Tumor Suppressor Gene

Gift from Val Skinner Foundation will Help Give CINJ Researchers an Enhanced View of Cancer Cell Metabolism

Process of Cancer Cell Self-Digestion is Target of New Cancer Therapies at CINJ

Reducing Cancer Risk in Children of Parents with Gene Mutations: A “Teachable Moment”

New Insight into the Biology of the BRCA1 Breast Cancer Gene

CINJ Nurses Present Anxiety Reduction Research


 

CINJF logo Click to visit the CINJ website